Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by jopatcloon Oct 15, 2024 6:56am
70 Views
Post# 36265878

BSEcho2024 pleasure to share the stage post Dario Freitas🚀

BSEcho2024 pleasure to share the stage post Dario Freitas🚀Interesting & remember on Dario Freitas (PHD study using Ventripoint - Dario Freitas) And I think they know more about the Ventripoint tech than the whiners on this board.I also think that Dr. Adams the visionary with Ventripoint will silence the denigrators with FDA V4.0. FDA V4.0 and Sales at any time now Insiders know! and now I think of Llphant too (GEHC) 
British Society Of Echocardiography 2024 conference in Edinburgh was such an amazing event!

I was thrilled to be able to co-chair the Tricuspid Regurgitation session with amazing speakers such as Dr Bushra Rana, Dr Abbas Zaidi
and Dr Victoria Delgado
!

On the top of that, we had an amazing Congenital session about AVSD where I had the pleasure to share the stage with speakers such as Prof Karen P McCarthy, Prof Mark Danton, Dr Amanda Hunter and Dr Chris Rush. Thank you all for your amazing contributions!

Last but not least, thank you to Ian Mcleod and GE HealthCare for the opportunity to teach in the congenital echo workshop.

Joanne Sopala, Hatty Grant and team, you did an amazing job! Congratulations to all of you
 
 
 
 

 

 
Add a comment…
 
 

<< Previous
Bullboard Posts
Next >>